Department of Clinical Genetics, Hospital of Rehabilitation of Craniofacial Anomalies, University of São Paulo (HRAC/USP), Bauru, São Paulo, Brazil.
Am J Med Genet A. 2013 Aug;161A(8):2088-94. doi: 10.1002/ajmg.a.36057. Epub 2013 Jul 9.
Mutations in solute carrier family 26 (sulfate transporter), member 2 (SLC26A2) gene result in a spectrum of autosomal recessive chondrodysplasias that range from the mildest recessive form of multiple epiphysial dysplasia (rMED) through the most common diastrophic dysplasia (DTD) to lethal atelosteogenesis type II and achondrogenesis IB. The clinical variability has been ascribed to quantitative effect of mutations of the sulfate transporter activity. Here we describe two Brazilian sisters, born to healthy and non consanguineous parents, with Robin sequence, mild shortening of upper and lower limbs, brachymetacarpalia/tarsalia, additional and accelerated carpal ossification, marked genu valgum, and multiple epiphysial dysplasia. This phenotype was intermediate between DTD and rMED, and both girls have a compound heterozygous mutations for the SLC26A2, a Finnish founder mutation (c.-26 + 2T>C), and R279W. This combination of mutations has been observed in individuals with different phenotypes, including DTD, DTD variant, and rMED. The distinct phenotype of our cases reinforces the hypothesis that other factors may be influencing the phenotype as previously suggested.
溶质载体家族 26(硫酸盐转运体)成员 2 基因(SLC26A2)的突变导致常染色体隐性软骨发育不全的一系列表现型,范围从最轻微的多发性骨骺发育不良(rMED)到最常见的 diastrophic 发育不良(DTD),再到致死性的 II 型软骨发育不全和 IB 型软骨发育不全。这种临床表现的多样性归因于硫酸盐转运体活性的突变的定量效应。在这里,我们描述了两位巴西姐妹,她们出生于健康且非近亲的父母,患有 Robin 序列、四肢轻度缩短、短掌骨/跗骨、额外和加速的腕骨/跗骨骨化、明显的膝内翻和多发性骨骺发育不良。这种表型介于 DTD 和 rMED 之间,两个女孩均携带 SLC26A2 的复合杂合突变,即芬兰的 founder 突变(c.-26 + 2T>C)和 R279W。这种突变组合在具有不同表型的个体中均有观察到,包括 DTD、DTD 变体和 rMED。我们的病例的独特表型强化了其他因素可能影响表型的假说,正如之前所提出的。